Canadian stock index futures rose on Tuesday, as higher commodity prices and easing geopolitical tensions put the main benchmark on track for a strong quarterly performance.
The TSX Composite Index dropped 156.18 points to close Monday at 34,823.82.
September futures were up 6.20 points, or 0.30%, signaling a positive open for the markets.
The Canadian dollar slid 0.12 cents at 70.25 cents U.S.
The index was poised for a 6.3% rise in the second quarter, still lagging U.S. peer S&P 500, which is on track for a 14% gain.
The index was on track for its eighth straight quarter of gains, the benchmark's longest winning streak since January 1995-October 1996.
Meanwhile, U.S. President Donald Trump's administration is expected to formally declare on Wednesday that it will ?not extend the U.S.-Mexico-Canada Agreement (USMCA) on trade, starting a decade-long clock to wind down the 32-year-old North American free trade zone as the three countries haggle over proposed changes.
On the economic slate, Statistics Canada reported real gross domestic product grew 0.5% in April, marking its largest expansion since July 2025.
ON BAYSTREET
The TSX Venture Exchange dipped 4.75 points Monday to 891.09.
ON WALLSTREET
U.S. stock futures were higher on Tuesday after the Dow Jones Industrial Average rose to a fresh record close, with Wall Street set to close out a strong first half and second quarter.
Futures for the Dow Jones Industrials gave up 28 points to 52,544.
Futures for the S&P 500 index inched higher 1.75 points to 7,502.
Futures for the NASDAQ Composite picked up 35.75 points to 29,088.50.
The Dow has climbed 8.6% in the first six months of the year, putting it on pace for its best first-half performance since 2021, when it jumped 12.7%.
The S&P 500 is also up more than 8% in the first half, while the NASDAQ has outperformed with an 11.1% advance.
The S&P 500 and NASDAQ have risen about 14% and 19.6%, respectively, for Q2, on pace for their biggest quarterly gain since the second quarter of 2020. The Dow has gained 12.6% in that time, headed for its strongest quarter since Q4 2022.
Merck shares lost 0.6%, while AbbVie slid 0.5%, after Reuters reported that a U.S. House committee began a probe into whether the drugmakers were involved in trials that took place in China that aided the country’s military capabilities.
In Japan, the Nikkei 225 perked 0.9% Tuesday, while in Hong Kong, the Hang Seng retreated 0.6%.
Oil prices rallied 46 cents to 71.21 cents U.S. a barrel.
Gold prices gained $2.70 to $4,041.60 U.S an ounce.
